Post-surgical infections can pump up hospital costs by $60,000

Underscoring the importance of fighting antibiotic-resistant infections, a new study has concluded that surgical patients whose incisions are infected by such bugs are at much greater risk for re-hospitalization and death. It also concluded that treating these infections add as much as $60,000 per patient to their hospital bill.

To examine the impact of antibiotic-resistant infections, Duke University Medical Center researchers looked at 90-day postoperative outcomes for 659 patients, some with MRSA and some infected with methicillin-susceptible Staphylococcus aureus (MSSA).

Patients with MRSA averaged three additional weeks of hospitalization and $60,000 more in hospital costs than patients who were never infected. Also, patients with MRSA-related surgical site infections were 35 times more likely to be re-hospitalized and seven times more likely to die within 90 days than patients who didn't contract such an infection.

To learn more about the study:
- read this HealthDay News piece

Related Articles:
Researchers making headway against MRSA
MRSA invading hospitals through outpatient traffic
Study: Community MRSA infection rates increasing

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.